Transcatheter Mitral Valve Replacement: Update on New Devices

Transcatheter heart-valve replacement: update.

Update on transcatheter aortic valve replacement.

Transcatheter aortic valve replacement (TAVR) is currently the treatment modality of choice for patients with symptomatic severe aortic stenosis who are inoperable or at high risk for surgical aortic valve replacement. TAVR has shown a clear mortality benefit compared to conservative treatment in inoperable patients and is at least non-inferior to surgical aortic valve replacement in high-risk ...

Transcatheter Aortic Valve Replacement: A Review Article

Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...

Transcatheter mitral valve repair and replacement.

New generation devices for transcatheter aortic valve replacement

Transcatheter aortic valve replacement (TAVR), performed for the first time in 2002 by Alain Cribier, is the approved treatment for patients with symptomatic severe aortic stenosis who are inoperable or at high risk for surgery. Recently, TAVR has been evaluated in the subgroup of patients with intermediate risk. Despite the favorable evolution of first-generation devices, some issues, such as ...